Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Genzyme Sells Pharma Intermediates Business to ICIG
11:18 AM MST | March 9, 2011 | Deepti Ramesh
Biotechnology company Genzyme (Cambridge, MA) says it has completed the sale of its pharmaceutical intermediates business to the International Chemical Investors Group (ICIG; Frankfurt). Financial terms of the deal were not disclosed. ICIG purchased all of the pharmaceutical intermediates business, excluding the drug delivery technologies unit. The acquired business has been renamed Corden Pharma Switzerland and will operate as part of ICIG’s pharmaceutical business within the Corden Pharma group. The Corden Pharma group is the pharmaceutical market...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee